Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials
about
Fondaparinux in the management of patients with ST-elevation acute myocardial infarctionLow-molecular-weight heparins as adjunctive therapy to thrombolytics: extracting the best data.Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registryEarly management of ST elevation myocardial infarction: a review of practice.The impact of bleeding in patients with acute coronary syndromes: how to optimize the benefits of treatment and minimize the risk.Myocardial infarction: contemporary management strategies.Efficacy and safety of fondaparinux in patients with acute coronary syndromes.Utilizing enoxaparin in the management of STEMI.Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes.New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implicationsAcute coronary syndromes: Diagnosis and management, part II.Efficacy and Safety of Low-Molecular-Weight Heparins As An Adjunct to Thrombolysis in Acute ST-Elevation Myocardial Infarction.Enoxaparin in patients with primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction.Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis.Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus.ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
P2860
Q28219415-E36DA562-8909-414D-B3D9-7E7F0096B917Q31039802-500134BF-C0B9-4D67-B685-6A2DE4C61EF3Q34196711-0720F65C-C047-40B8-9EB8-8E3A9850997BQ36739783-E5ED47EC-400E-4F3C-826B-BC8A57CB679DQ36861495-41FDCBD3-27E9-4B3B-87F7-C6ACD4854DFBQ36863859-3151A0D9-F7D5-4A48-9ACD-FA3F1A05CA79Q37012898-451973D2-624E-4711-BCC2-B2E70F0E9BE7Q37031371-92A00AFA-7EFE-4F0F-9C8A-4F3861FC091EQ37175915-2D2A65EB-8943-4A69-92FD-28510FEE0685Q37193906-654DA7E4-2BA8-489D-ACE2-F84A019E8EE8Q37406719-813B3C68-7FE4-44CF-9F30-B5791DA3B6FDQ37414802-652226B2-42B9-4E43-AB08-12492E8495D1Q37445888-0EC404B3-0E17-4B99-9870-E6C4A10CC4F5Q37781944-A082D7AC-23C0-4B36-AFAF-D4CACD2E2478Q37997963-C3E7AFE7-F649-4C09-9150-31FC5BE41EC2Q50665407-C225AA85-999F-4157-8D82-F511650A7F80
P2860
Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Unfractionated and low-molecul ...... lysis of the randomized trials
@ast
Unfractionated and low-molecul ...... lysis of the randomized trials
@en
Unfractionated and low-molecul ...... lysis of the randomized trials
@nl
type
label
Unfractionated and low-molecul ...... lysis of the randomized trials
@ast
Unfractionated and low-molecul ...... lysis of the randomized trials
@en
Unfractionated and low-molecul ...... lysis of the randomized trials
@nl
prefLabel
Unfractionated and low-molecul ...... lysis of the randomized trials
@ast
Unfractionated and low-molecul ...... lysis of the randomized trials
@en
Unfractionated and low-molecul ...... lysis of the randomized trials
@nl
P2093
P921
P1433
P1476
Unfractionated and low-molecul ...... lysis of the randomized trials
@en
P2093
Alexander G Turpie
Daniel J Quinlan
Ian B Menown
Shamir R Mehta
P304
P356
10.1161/CIRCULATIONAHA.105.573550
P407
P577
2005-12-20T00:00:00Z